Lysosomal Storage Disease (LSD) Market Report

China Lysosomal Storage Disease (LSD) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：194
  • REPORT CODE：GMM1757534
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Lysosomal Storage Disease (LSD) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Arena Pharmaceuticals

    • Eli Lilly

    • Biomarin Pharmaceutical

    • Amicus Therapeutics

    • Lexicon Pharmaceuticals

    • Astrazeneca

    • Astellas Pharma

    • Merck

    • Actelion Pharmaceuticals

    By Type:

    • Glycoprotein Metabolism Disorder

    • Lipid Metabolism Disorder

    By Application:

    • Hospitals

    • Others

    • Clinics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Lysosomal Storage Disease (LSD) Market Overview 2018-2029

    • 1.1 China Lysosomal Storage Disease (LSD) Industry Development Overview

    • 1.2 China Lysosomal Storage Disease (LSD) Industry Development History

    • 1.3 China Lysosomal Storage Disease (LSD) Industry Market Size (2018-2029)

    • 1.4 China Lysosomal Storage Disease (LSD) Market Analysis by Type from Production Side

      • 1.4.1 China Lysosomal Storage Disease (LSD) Production Volume, Production Value and Growth Rate of Glycoprotein Metabolism Disorder (2018-2029)

      • 1.4.2 China Lysosomal Storage Disease (LSD) Production Volume, Production Value and Growth Rate of Lipid Metabolism Disorder (2018-2029)

    • 1.5 China Lysosomal Storage Disease (LSD) Market Analysis by Application from Consumption End

      • 1.5.1 China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • 1.6 China Lysosomal Storage Disease (LSD) Market Analysis by Region

      • 1.6.1 North China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Lysosomal Storage Disease (LSD) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Lysosomal Storage Disease (LSD) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Lysosomal Storage Disease (LSD) Market Status and Competition Analysis in 2023

      • 2.2.3 China Lysosomal Storage Disease (LSD) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Lysosomal Storage Disease (LSD) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Lysosomal Storage Disease (LSD) Industry Development

    Chapter 3 Lysosomal Storage Disease (LSD)Industry Chain Analysis

    • 3.1 Lysosomal Storage Disease (LSD) Industry Chain

    • 3.2 Lysosomal Storage Disease (LSD) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Lysosomal Storage Disease (LSD) Market

    • 3.3 Lysosomal Storage Disease (LSD) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Lysosomal Storage Disease (LSD) Market

    Chapter 4 China Lysosomal Storage Disease (LSD) Market, by Type

    • 4.1 China Lysosomal Storage Disease (LSD) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Lysosomal Storage Disease (LSD) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Lysosomal Storage Disease (LSD) Production Volume and Growth Rate, by Type

      • 4.5.1 China Lysosomal Storage Disease (LSD) Production Volume and Growth Rate of Glycoprotein Metabolism Disorder

      • 4.5.2 China Lysosomal Storage Disease (LSD) Production Volume and Growth Rate of Lipid Metabolism Disorder

    Chapter 5 China Lysosomal Storage Disease (LSD) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Lysosomal Storage Disease (LSD) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Lysosomal Storage Disease (LSD) Market Size and Growth Rate, by Application

      • 5.5.1 China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Hospitals

      • 5.5.2 China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Others

      • 5.5.3 China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Clinics

    Chapter 6 China Lysosomal Storage Disease (LSD) Market, by Region

    • 6.1 China Lysosomal Storage Disease (LSD) Production Volume and Production Value, by Region

    • 6.2 China Lysosomal Storage Disease (LSD) Sales Volume and Sales Value, by Region

    Chapter 7 North China Lysosomal Storage Disease (LSD) Market Analysis

    • 7.1 North China Lysosomal Storage Disease (LSD) Market, by Type

    • 7.2 North China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 8 Central China Lysosomal Storage Disease (LSD) Market Analysis

    • 8.1 Central China Lysosomal Storage Disease (LSD) Market, by Type

    • 8.2 Central China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 9 South China Lysosomal Storage Disease (LSD) Market Analysis

    • 9.1 South China Lysosomal Storage Disease (LSD) Market, by Type

    • 9.2 South China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 10 East China Lysosomal Storage Disease (LSD) Market Analysis

    • 10.1 East China Lysosomal Storage Disease (LSD) Market, by Type

    • 10.2 East China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 11 Northeast China Lysosomal Storage Disease (LSD) Market Analysis

    • 11.1 Northeast China Lysosomal Storage Disease (LSD) Market, by Type

    • 11.2 Northeast China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 12 Southwest China Lysosomal Storage Disease (LSD) Market Analysis

    • 12.1 Southwest China Lysosomal Storage Disease (LSD) Market, by Type

    • 12.2 Southwest China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 13 Northwest China Lysosomal Storage Disease (LSD) Market Analysis

    • 13.1 Northwest China Lysosomal Storage Disease (LSD) Market, by Type

    • 13.2 Northwest China Lysosomal Storage Disease (LSD) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Arena Pharmaceuticals

        • 14.1.1 Arena Pharmaceuticals Company Profile

        • 14.1.2 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Eli Lilly

        • 14.2.1 Eli Lilly Company Profile

        • 14.2.2 Eli Lilly Lysosomal Storage Disease (LSD) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Biomarin Pharmaceutical

        • 14.3.1 Biomarin Pharmaceutical Company Profile

        • 14.3.2 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Amicus Therapeutics

        • 14.4.1 Amicus Therapeutics Company Profile

        • 14.4.2 Amicus Therapeutics Lysosomal Storage Disease (LSD) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Lexicon Pharmaceuticals

        • 14.5.1 Lexicon Pharmaceuticals Company Profile

        • 14.5.2 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Astrazeneca

        • 14.6.1 Astrazeneca Company Profile

        • 14.6.2 Astrazeneca Lysosomal Storage Disease (LSD) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Astellas Pharma

        • 14.7.1 Astellas Pharma Company Profile

        • 14.7.2 Astellas Pharma Lysosomal Storage Disease (LSD) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck

        • 14.8.1 Merck Company Profile

        • 14.8.2 Merck Lysosomal Storage Disease (LSD) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Actelion Pharmaceuticals

        • 14.9.1 Actelion Pharmaceuticals Company Profile

        • 14.9.2 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Lysosomal Storage Disease (LSD) Industry Research Conclusions

    • 15.2 Lysosomal Storage Disease (LSD) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Lysosomal Storage Disease (LSD) Industry Market Size (2018-2029)

    • Figure China Lysosomal Storage Disease (LSD) Production Volume, Production Value and Growth Rate of Glycoprotein Metabolism Disorder (2018-2029)

    • Figure China Lysosomal Storage Disease (LSD) Production Volume, Production Value and Growth Rate of Lipid Metabolism Disorder (2018-2029)

    • Figure China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Lysosomal Storage Disease (LSD) Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure North China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure Central China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure South China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure East China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Lysosomal Storage Disease (LSD) Market Size and Growth Rate from 2018-2029

    • Figure Lysosomal Storage Disease (LSD) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Lysosomal Storage Disease (LSD) Market Share by Type in 2018

    • Figure China Lysosomal Storage Disease (LSD) Market Share by Type in 2023

    • Figure China Lysosomal Storage Disease (LSD) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Production Volume and Growth Rate of Glycoprotein Metabolism Disorder (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Production Volume and Growth Rate of Lipid Metabolism Disorder (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Market Share by Application in 2018

    • Figure China Lysosomal Storage Disease (LSD) Market Share by Application in 2023

    • Figure China Lysosomal Storage Disease (LSD) Total Market Size and Growth Rate from Consumption End

    • Figure China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Market Size and Growth Rate of Clinics (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Production Volume by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Production Volume Share by Region (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Production Volume Share by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Production Value by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Production Value Share by Region (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Production Value Share by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Sales Volume by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Sales Volume Share by Region (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Sales Volume Share by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Sales Value by Region (2018-2023)

    • Table China Lysosomal Storage Disease (LSD) Sales Value Share by Region (2018-2023)

    • Figure China Lysosomal Storage Disease (LSD) Sales Value Share by Region (2018-2023)

    • Table North China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table North China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure North China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table North China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table North China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure North China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table Central China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table Central China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure Central China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table Central China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table Central China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure Central China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table South China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table South China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure South China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table South China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table South China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure South China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table East China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table East China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure East China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table East China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table East China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure East China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table Northeast China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table Northeast China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table Northeast China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table Southwest China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table Southwest China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table Southwest China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Lysosomal Storage Disease (LSD) Production Volume by Type (2018-2023)

    • Table Northwest China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Lysosomal Storage Disease (LSD) Production Volume Share by Type (2018-2023)

    • Table Northwest China Lysosomal Storage Disease (LSD) Sales Volume by Application (2018-2023)

    • Table Northwest China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Lysosomal Storage Disease (LSD) Sales Volume Share by Application (2018-2023)

    • Table Arena Pharmaceuticals Company Profile

    • Table Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Biomarin Pharmaceutical Company Profile

    • Table Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Amicus Therapeutics Company Profile

    • Table Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Lexicon Pharmaceuticals Company Profile

    • Table Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Astrazeneca Company Profile

    • Table Astrazeneca Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)

    • Table Actelion Pharmaceuticals Company Profile

    • Table Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US